Zemplar (Paricalcitol) Injection is a medication used to prevent and treat secondary hyperparathyroidism in patients with chronic kidney disease (CKD). Secondary hyperparathyroidism is a condition where the parathyroid glands produce too much parathyroid hormone (PTH) due to low levels of calcium in the blood, often seen in CKD patients.
Key Details:
Generic Name: Â Paricalcitol
Brand Name: Zemplar
Formulation: Injection
Concentration: 5 mcg/mLÂ
Volume: 1 mL
Packaging: Single Dose Vials
Manufacturer: AbbVie
Uses:
Zemplar is primarily used in patients with chronic kidney disease (CKD) on dialysis to manage and prevent secondary hyperparathyroidism.
 Â
Mechanism of Action:
Paricalcitol is a synthetic vitamin D analog. It works by inhibiting the secretion of PTH while maintaining calcium and phosphorus levels in the blood, which helps to reduce the complications associated with bone disease and other related conditions in CKD patients.
Â
Administration:
This injection is administered intravenously, typically during dialysis sessions, as per the dosage prescribed by a healthcare provider.
Â
Important Considerations:
- Dosage should be tailored to individual patient needs and based on PTH, calcium, and phosphorus levels.
- Regular monitoring of blood levels is essential to avoid complications such as hypercalcemia (high calcium levels).
- Patients should inform their healthcare provider of any other medications they are taking to avoid potential interactions.
Â
Potential Side Effects:
- Common side effects include nausea, vomiting, and increased levels of calcium in the blood.
- Serious but less common side effects may include allergic reactions, dizziness, and increased risk of cardiovascular issues.Â
As always, healthcare providers should be consulted for personalized medical advice and to ensure the safe and effective use of this medication.
Skip to content
